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Background/Aims: Pandemic influenza A (H1N1) virus infection presents with variable severity. However, little is known 
about clinical predictors of disease severity. We studied the clinical predictors of severe pandemic H1N1 pneumonia and 
their correlation with radiological findings.
Methods: We reviewed medical and radiological records of adults with pandemic H1N1 pneumonia. After classification 
of patients into severe and non-severe groups, the following data were evaluated: demographic data, pneumonia severity 
index (PSI), CURB65, risk factors, time to first dose of antiviral medication, routine laboratory data, clinical outcome, and 
radiological characteristics.
Results: Of 37 patients with pandemic H1N1 pneumonia, 12 and 25 were assigned to the severe and non-severe 
groups, respectively. PSI score, serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), and lactate 
dyhydrogenase (LDH) levels were higher in the severe group than in the non-severe group (p = 0.035, 0.0003, 0.0023, 
and 0.0002, respectively). AST, ALT, and LDH levels were positively correlated with the radiological findings (p < 0.0001, 
0.0003, and < 0.0001, respectively) and with the number of involved lobes (p = 0.663, 0.0134, and 0.0019, respectively). 
The most common finding on high resolution computed tomography (HRCT) scans was ground-glass attenuation with 
consolidation (n = 22, 60%), which had a predominantly patchy distribution (n = 31).
Conclusions: We demonstrated a positive correlation between clinical findings, such as serum AST, ALT, and LDH levels, 
and radiological findings. A combination of clinical and HRCT indicators would be useful in predicting the clinical outcome 
of pandemic H1N1 pneumonia. (Korean J Intern Med 2011;26:160-167)
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INTRODUCTION
Since the beginning of the 2009 influenza A (H1N1) 
pandemic, the cumulative number of infected people has 
increased rapidly [1,2]. Pneumonia has been reported as 
the major cause of hospitalization and death in confirmed 
cases of H1N1 [3-6]. However, there are limited data on 
the clinical predictors of severity and radiological features 
of pandemic H1N1 pneumonia. 
Delayed antiviral treatment, severe hypoxemia, and 
multisystem organ failure have been reported to be 
significant negative prognostic factors among critically 
ill patients with pandemic H1N1 infection [7-11], while 
early diagnosis and assessment of high risk are likely 
to be important for successful treatment. It has been a 
challenge to differentiate pandemic H1N1 pneumonia from 
community-acquired pneumonia of bacterial origin or 
from pulmonary disease occurring from other causes. 
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Thus, it is important to understand the clinical and 
radiological features of pandemic H1N1 pneumonia to 
facilitate early diagnosis and assessment of risk. The aim of 
this study was to find clinically useful predictors of severity 
and radiological features characteristic of pandemic H1N1 
pneumonia. We studied the clinical predictors of the 
severe form of pandemic H1N1 pneumonia and explored 
the correlation of these predictors with high resolution 
computed tomography (HRCT) findings.
METHODS
Patient selection criteria
Thirty-seven adults who presented with confirmed 
pandemic H1N1 pneumonia at the Pusan National 
University Hospital and Pusan National University Yangsan 
Hospital, Korea, between August 1, 2009 and November 
30, 2009 were recruited. Pandemic H1N1 infection was 
confirmed by a real-time RT-PCR assay performed 
on specimens aspirated from the nasopharyngeal or 
endotracheal tubes. Specimens were collected at the time 
of admission. Pneumonia was defined as the presence 
of acute respiratory symptoms and parenchymal lesions 
in the HRCT scan, which was performed at the time of 
admission. Patients who did not undergo the HRCT scan 
or were below 18 years old were excluded.
Patients were classified into two groups according to the 
clinical severity of the disease at the time of presentation: 
severe and non-severe groups. The severe group included; 
1) patients requiring mechanical ventilation, 2) those 
requiring intravenous infusion of inotropic medication, or 
3) those with a PaO2/FiO2 ratio ≤ 250 [12]. 
This study was approved by the Institutional Review 
Board of Pusan National University Hospital.
Clinical data
We performed a retrospective review of the medical 
charts and radiological and laboratory records to obtain 
demographic data, pneumonia severity index (PSI) 
scores [13], CURB65 [14], comorbidity, time to first dose 
of antiviral medication, routine laboratory data, clinical 
outcome, and radiological characteristics.
Image interpretation
Six locations in each patient (right upper lobe, right 
middle lobe, right lower lobe, left upper lobe, lingular 
segment, left lower lobe) were evaluated for the presence of 
lung lesions and other abnormal findings. The computed 
tomography (CT) images were reviewed independently 
by two experienced chest radiologists who reached 
a consensus regarding the findings and extent of the 
disease. The CT scans were evaluated retrospectively for 
consolidation, air-bronchogram, ground-glass attenuation 
(GGA), GGA with intralobular reticular opacity (“crazy-
paving” appearance), centrilobular nodules, bronchial wall 
thickening, interlobular septal thickening, pleural effusion, 
and hilar or mediastinal lymph node enlargement. 
Laterality (unilateral or bilateral) and the number of 
involved lobes of lung lesions were also analyzed. The 
visual analysis on the extent of consolidation and GGA 
on the CT image was subjectively performed using a 10% 
scale.









Mean age, yr (range) 46.1 ± 17.3 (18-79) 46.3 ± 18.4 (20-62) 46.0 ± 15.4 (18-79) 0.867
Male 21 (57) 6 (50)  15 (60)   0.5654
Comorbidity 18 (49) 8 (67)  10 (40)  0.1287
CURB65 0.65 ± 0.97 1.00 ± 1.12 0.48 ± 0.87  0.1601
Pneumonia severity index 60.0 ± 39.0 83.4 ± 45.7 48.9 ± 30.4 0.035
Time to antiviral treatment, day 5.27 ± 2.95  6.41 ± 4.44 4.72 ± 1.77   0.2675
Shock 4 4 0
Acute respiratory distress syndrome 5 5 0
Mechanical ventilation 8 8 0
Death 5 5 0
Values are presented as mean ± SD or number (%).162    The Korean Journal of Internal Medicine Vol. 26, No. 2, June 2011
Statistical analysis
The Mann-Whitney U test was used to analyze 
continuous variables. Categorical variables were compared 
using the chi-squared test or Fisher’s exact test. The 
Pearson correlation coefficient was used to evaluate 
correlations between clinical variables and the degree 
of radiological involvement. Statistical analyses were 
performed using the SAS version 9.1 (SAS Inc., Cary, NC, 
USA). In all analyses, p < 0.05 (two-sided) was taken to 
indicate statistical significance.
RESULTS
Demographic and clinical characteristics
Of the 1,012 adults diagnosed with pandemic H1N1 
infection during the study period, 46 patients (4.5%) were 
hospitalized and 37 patients (3.7%) were confirmed to 
have H1N1 pneumonia, based on HRCT findings. Five of 
these 37 patients died (13.5%).
The demographic and clinical characteristics of the 
patients are described in Table 1. The mean age of the 
group was 46.1 years. Twenty-one patients (57%) were 
males. Eighteen patients (49%) had underlying conditions, 
such as chronic pulmonary disease and metabolic 
disorders (primarily diabetes mellitus), which were the 
most commonly noted comorbidities and were risk factors 
for severe pandemic H1N1 (Table 2). Twelve patients 
were assigned to the severe group and 25 to the non-
severe group. There was no significant difference in the 
demographic or clinical data between the two groups. 
Of the 12 patients in the severe group, eight required 
mechanical ventilation, five had acute respiratory distress 
syndrome (ARDS), and four presented with shock. Of the 
five patients who died, two died of ARDS. The remaining 
three patients died from sudden cardiac death (n = 1), 
multi-organ failure (n = 1), and exacerbation of underlying 
chronic obstructive pulmonary disorder (n = 1).
The mean PSI and CURB65 scores were 60 and 0.65 
points, respectively. The mean PSI score of the severe 
group was higher than that of the non-severe group 
(p = 0.035). However, we found no significant difference 
in CURB65 values between the groups. The mean time to 
first dose of antiviral medication was 5.27 days and was 
not significantly different between the groups (p = 0.2675).
There was no statistically significant difference in mean 
leukocyte count, lymphocyte count, or C-reactive protein 
level between the groups (Table 3). However, the levels 
of serum aspartate aminotransferase (AST), alanine 
aminotransferase (ALT), and lactate dehydrogenase 
(LDH) were significantly higher in the severe group than 
in the non-severe group (p = 0.0003, 0.0023, and 0.0002, 
respectively).
Table 2. Most common risk factors for study patients
Comorbidity Case (n = 37)
Chronic pulmonary disease 8
Metabolic disorder 5
Chronic cardiovascular disease (excluding
  isolated hypertension)
2
Chronic renal disease 1
Obesity (body mass index  > 30) 1
Pregnancy 1
Immunosuppressed state (drug, human 
  immunodeficiency virus, hematological 
  disorder)
1
Chronic liver disease 0
None 19
Table 3. Laboratory findings and degree of radiological involvement
Variables Total Severe group Non-severe group p value
Aspartate aminotransferase, U/L    50.9 ± 42.4  91.3 ± 33.1  31.5 ± 17.3 0.0003
Alanine aminotransferase, U/L    34.4 ± 26.8  53.5 ± 23.2   25.2 ± 13.8 0.0023
Lactate dehydrogenase, U/L  620.1 ± 356.1  945.0 ± 285.2  464.2 ± 151.9 0.0002
Leukocytes, /mm
3 9,006 ± 5241 8,393 ± 3984 9,300 ± 4015 0.5120
Lymphocytes, /mm
3        1,062 ± 715         1,016 ± 498        1,085 ± 574 0.5957
C-reactive protein  12.3 ± 17.3  9.4 ± 6.4   13.7 ± 15.7 0.4899
Radiological extent, %  28.2 ± 23.5   50.0 ± 18.6   17.8 ± 10.0 0.0017
Involved lobes, n  4.2 ± 1.7   5.1 ± 1.1  3.8 ± 1.3 0.0301
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HRCT findings
The HRCT findings are summarized in Table 4. HRCT 
scans were performed within 15 days of the onset of 
symptoms. The most common findings were ground-glass 
attenuation with consolidation (n = 22, 60%), ground 
glass attenuation alone (n = 13, 35%), and consolidation 
alone (n = 2, 5%). The distribution in the axial plane was 
predominantly patchy (n = 31), although some patients 
showed a diffuse distribution (n = 6). Patchy distribution 
of GGA and/or consolidation were seen predominantly at 
the peripheral subpleural space in 19 patients (51%) and 
were random in 12 patients (33%) (Fig. 1). GGA and/or 
consolidation were predominant in the lower lung zone 
in 10 patients (27%). There was no craniocaudal zonal 
predominance in the remaining patients. The areas of 
consolidation were surrounded by GGA in all patients 
with consolidation and GGA (n = 22). “Crazy-paving” 
appearance, defined by intralobular interstitial thickening 
in the area of GGA, was observed in 14 patients (38%) 
(Fig. 2). Poorly marginated centrilobular nodules were 
seen in 22 patients (59%). Bilateral involvement was more 
common (n = 30, 81%) than unilateral involvement (n = 7, 
19%).
The extent of consolidation and GGA was significantly 
higher (p = 0.0017) in the severe group (average, 50%; 10 
to 90%) than in the non-severe group (average, 17.8%; 5 
to 50%). Other HRCT findings did not differ significantly 
between the groups. We found small pleural effusion 
in seven patients (19%) and hilar or mediastinal 
lymph node enlargement in two (5%). Spontaneous 
pneumomediastinum was seen in one patient (3%). No 
patient had pulmonary thromboembolism (PE).
Correlations between clinical predictors and 
degree of radiological involvement
We found significant differences in the PSI score, 
AST, ALT, and LDH levels between the two groups. The 
Pearson correlation coefficient was used to evaluate the 
correlations between these parameters and the degree 
of radiological involvement. The results indicated that 
AST, ALT, and LDH levels were correlated with the extent 
of consolidation and GGA (p < 0.0001, 0.0003, and 
< 0.0001, respectively) and the number of involved lobes 
(p = 0.663, 0.0134, and 0.0019, respectively). LDH showed 
the strongest correlation with the degree of radiological 
involvement.
DISCUSSION
Several clinical features were identified as indicative of 
severe disease early in the 2009 H1N1 pandemic [7-11]. 
As age, comorbidity, and timing of the antiviral treatment 
were described as the most important prognostic factors, 
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we evaluated the clinical significance of these factors and 
studied their correlations with radiological features in 
severe pandemic H1N1 pneumonia.
This pandemic had some unusual features of severe 
disease in comparison with previous influenza pandemics 
[7-10,15]. While these studies suggested that pandemic 
H1N1 infection caused severe disease in previously healthy 
and young subjects, other studies [16,17] showed the 
highest mortality rates in those aged 50 years and older. 
It is thus unclear whether age is, in fact, a risk factor for 
severe disease. These conflicting observations may have 
been due to the presence of comorbidities commonly 
seen in patients aged 50 and older. However, there was 
no significant difference in mean age or frequency of 
comorbidities between the severe and non-severe groups 
in our study population.
Previous studies [18-20] indicated that prompt antiviral 
treatment can shorten the duration of seasonal influenza. 
Maximal benefit was seen when treatment was begun 
within the first 24-30 hours of onset. Patients with 
pandemic H1N1 infection in whom antiviral treatment 
was started within the first 48 hours showed significantly 
fewer fatalities [16]. Only six of the patients in our study 
began antiviral treatment within the first 48 hours. 
Although delayed antiviral treatment was suggested to be 
a risk factor for pandemic H1N1 pneumonia, our results 
only showed a trend towards a greater delay in the severe 
group, with no statistically significant difference in the 
Figure 1. Fifty-five-year-old woman with mild influenza A (H1N1) pneumonia. High resolution computed tomography scans showed 
multiple patchy areas of consolidation and ground glass attenuation in middle and lower zones of bilateral lungs.
Figure 2. Sixty-one-year-old woman with severe influenza A (H1N1) pneumonia. High resolution computed tomography scans showed 
diffuse area of consolidation and ground glass attenuation predominantly in lower lung zones. Note crazy-paving appearance (arrows).Cho WH, et al. Useful predictors of severe H1N1 pneumonia    165
mean time to antiviral treatment between the severe and 
non-severe groups.
PSI and CURB65 are clinical tools that predict 
morbidity and mortality in patients with community-
acquired pneumonia. CURB65 measures illness activity, 
whereas PSI was developed to predict the likelihood of 
mortality [21]. We measured PSI and CURB65 in our study 
population to evaluate the efficacy of these predictive 
tools. A significant difference was observed in PSI, but not 
in CURB65, between the groups, suggesting that PSI may 
be helpful for predicting the clinical outcome of severe 
pandemic H1N1 pneumonia. However, as the role of age 
(the most important factor contributing to PSI) is unclear 
in pandemic H1N1 pneumonia, these results should be 
interpreted with caution.
We reviewed the laboratory and radiological findings of 
pandemic H1N1 pneumonia and used univariate analysis 
to compare these findings with the severity of disease. 
The two groups differed significantly in serum levels of 
AST, ALT, and LDH. Although these laboratory findings 
can be observed in liver disease, there was no evidence of 
hepatotoxicity from other causes, such as history of drug 
use, preexisting liver disease, or positive viral markers 
for acute hepatitis. With regard to radiological findings, 
the two study groups differed significantly in the extent 
of GGA or consolidation and the number of involved 
lobes. We examined correlations between these findings 
and the degree of radiological involvement to explore 
the clinical utility of these markers. AST, ALT, and LDH 
levels were correlated with the degree of radiological 
involvement, with LDH showing the strongest correlation. 
These findings may be helpful in managing patients 
with pandemic H1N1 pneumonia. Although previous 
studies yielded similar laboratory findings in the severe 
form of pandemic H1N1 pneumonia, these studies did 
not correlate the findings with disease severity [7,8]. A 
recent study comparing differences between respiratory 
failure and non-respiratory failure groups among patients 
hospitalized with pandemic H1N1 pneumonia [11] showed 
that multisystem organ failure, lymphopenia, and delayed 
antiviral treatment were clinical predictors of respiratory 
failure. However, the study population included all age 
groups and approximately half of the subjects were 
younger than 18 years old. Different clinical courses were 
observed in the 2009 H1N1 pandemic depending on age 
group. Infants had the highest hospitalization rates and 
people aged 50 years and older had the highest mortality 
rates [16]. Age is thus an important consideration while 
interpreting the results of the present study.
Our results are consistent with those of recent studies 
indicating that diffuse or patchy areas of GGA mixed 
with consolidation were the most common findings on 
CT scans of H1N1 pneumonia patients [22-26]. Although 
influenza is not a predisposing factor for pulmonary 
thromboembolism, 36% of patients in the severe 
group were previously reported to have pulmonary 
thromboembolism [24,27-29]. The patients included 
in our study underwent routine contrast-enhanced CT 
scans, performed with an injection rate of 2 mL/sec 
and we found no case of pulmonary thromboembolism. 
These results may be explained by ethnic differences in 
the prevalence of PE. The crazy-paving appearance was 
common (38%) in our study population. Although this 
is a non-specific finding, commonly seen in pulmonary 
alveolar proteinosis, diffuse alveolar hemorrhage, atypical 
pulmonary infection, or near-drowning [30,31], the high 
prevalence of this finding among our H1N1 pneumonia 
cases is unique. The crazy-paving appearance was 
particularly common in the severe group, where the 
extent of pulmonary involvement was high. In addition 
to the other indices of severe H1N1 pneumonia in the 
present study, we also found a significantly greater extent 
of pulmonary involvement with GGA and consolidation 
among patients with severe pneumonia.
This study had some limitations. First, the small 
sample size and limited numbers of patients resulted in 
low statistical power in our analyses. Second, as only 
patients who visited the emergency room were included 
in our study population and patients with normal chest 
radiographs were not included, this may have resulted in 
over-representation of severe H1N1 pneumonia cases and 
under-representation of non-severe cases presenting with 
normal findings on chest radiography [24].
In conclusion, the results of the present study indicated 
that higher serum levels of AST, ALT, and LDH were 
significantly associated with severe pandemic H1N1 
pneumonia. The most common CT findings were 
bilateral subpleural patchy or diffuse areas of GGA 
and consolidation. Patients with severe illness had a 
significantly greater extent of lung involvement, based on 
a higher prevalence of crazy-paving appearance on HRCT 
scans. A combination of clinical and HRCT indicators may 
therefore aid in predicting the clinical course and outcome 
of pandemic H1N1 pneumonia.166    The Korean Journal of Internal Medicine Vol. 26, No. 2, June 2011
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